Global Parkinson's Disease Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced stages of the disease.
The Global Parkinson's Disease Therapeutics Market Size was estimated at USD 2646.12 million in 2023 and is projected to reach USD 3753.57 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Parkinson's Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease Therapeutics market in any manner.
Global Parkinson's Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Market Segmentation (by Type)
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Segmentation (by Application)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced stages of the disease.
The Global Parkinson's Disease Therapeutics Market Size was estimated at USD 2646.12 million in 2023 and is projected to reach USD 3753.57 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.
This report provides a deep insight into the global Parkinson's Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease Therapeutics market in any manner.
Global Parkinson's Disease Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Market Segmentation (by Type)
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Segmentation (by Application)
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinson's Disease Therapeutics Market
- Overview of the regional outlook of the Parkinson's Disease Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson's Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson's Disease Therapeutics Segment by Type
1.2.2 Parkinson's Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson's Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson's Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson's Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson's Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson's Disease Therapeutics Price by Type (2019-2024)
7 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson's Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.2 Global Parkinson's Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Parkinson's Disease Therapeutics Basic Information
9.1.2 Merck Parkinson's Disease Therapeutics Product Overview
9.1.3 Merck Parkinson's Disease Therapeutics Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Parkinson's Disease Therapeutics SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Akorn
9.2.1 Akorn Parkinson's Disease Therapeutics Basic Information
9.2.2 Akorn Parkinson's Disease Therapeutics Product Overview
9.2.3 Akorn Parkinson's Disease Therapeutics Product Market Performance
9.2.4 Akorn Business Overview
9.2.5 Akorn Parkinson's Disease Therapeutics SWOT Analysis
9.2.6 Akorn Recent Developments
9.3 GSK
9.3.1 GSK Parkinson's Disease Therapeutics Basic Information
9.3.2 GSK Parkinson's Disease Therapeutics Product Overview
9.3.3 GSK Parkinson's Disease Therapeutics Product Market Performance
9.3.4 GSK Parkinson's Disease Therapeutics SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Novartis
9.4.1 Novartis Parkinson's Disease Therapeutics Basic Information
9.4.2 Novartis Parkinson's Disease Therapeutics Product Overview
9.4.3 Novartis Parkinson's Disease Therapeutics Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
9.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
9.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Recent Developments
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
9.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
9.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Market Performance
9.6.4 Teva Pharmaceutical Business Overview
9.6.5 Teva Pharmaceutical Recent Developments
9.7 Abbvie
9.7.1 Abbvie Parkinson's Disease Therapeutics Basic Information
9.7.2 Abbvie Parkinson's Disease Therapeutics Product Overview
9.7.3 Abbvie Parkinson's Disease Therapeutics Product Market Performance
9.7.4 Abbvie Business Overview
9.7.5 Abbvie Recent Developments
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
9.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
9.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Market Performance
9.8.4 Kyowa Hakko Kirin Pharma Business Overview
9.8.5 Kyowa Hakko Kirin Pharma Recent Developments
9.9 Astellas Pharma
9.9.1 Astellas Pharma Parkinson's Disease Therapeutics Basic Information
9.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Overview
9.9.3 Astellas Pharma Parkinson's Disease Therapeutics Product Market Performance
9.9.4 Astellas Pharma Business Overview
9.9.5 Astellas Pharma Recent Developments
9.10 Roche
9.10.1 Roche Parkinson's Disease Therapeutics Basic Information
9.10.2 Roche Parkinson's Disease Therapeutics Product Overview
9.10.3 Roche Parkinson's Disease Therapeutics Product Market Performance
9.10.4 Roche Business Overview
9.10.5 Roche Recent Developments
9.11 H.Lundbeck
9.11.1 H.Lundbeck Parkinson's Disease Therapeutics Basic Information
9.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Overview
9.11.3 H.Lundbeck Parkinson's Disease Therapeutics Product Market Performance
9.11.4 H.Lundbeck Business Overview
9.11.5 H.Lundbeck Recent Developments
9.12 Bausch Health
9.12.1 Bausch Health Parkinson's Disease Therapeutics Basic Information
9.12.2 Bausch Health Parkinson's Disease Therapeutics Product Overview
9.12.3 Bausch Health Parkinson's Disease Therapeutics Product Market Performance
9.12.4 Bausch Health Business Overview
9.12.5 Bausch Health Recent Developments
9.13 Apokyn
9.13.1 Apokyn Parkinson's Disease Therapeutics Basic Information
9.13.2 Apokyn Parkinson's Disease Therapeutics Product Overview
9.13.3 Apokyn Parkinson's Disease Therapeutics Product Market Performance
9.13.4 Apokyn Business Overview
9.13.5 Apokyn Recent Developments
9.14 Orion
9.14.1 Orion Parkinson's Disease Therapeutics Basic Information
9.14.2 Orion Parkinson's Disease Therapeutics Product Overview
9.14.3 Orion Parkinson's Disease Therapeutics Product Market Performance
9.14.4 Orion Business Overview
9.14.5 Orion Recent Developments
9.15 Stada Arzneimittel
9.15.1 Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
9.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
9.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
9.15.4 Stada Arzneimittel Business Overview
9.15.5 Stada Arzneimittel Recent Developments
9.16 US WorldMeds
9.16.1 US WorldMeds Parkinson's Disease Therapeutics Basic Information
9.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Overview
9.16.3 US WorldMeds Parkinson's Disease Therapeutics Product Market Performance
9.16.4 US WorldMeds Business Overview
9.16.5 US WorldMeds Recent Developments
9.17 Desitin Arzneimittel
9.17.1 Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
9.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
9.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
9.17.4 Desitin Arzneimittel Business Overview
9.17.5 Desitin Arzneimittel Recent Developments
9.18 Endo Pharmaceuticals
9.18.1 Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
9.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
9.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Market Performance
9.18.4 Endo Pharmaceuticals Business Overview
9.18.5 Endo Pharmaceuticals Recent Developments
10 PARKINSON'S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Parkinson's Disease Therapeutics Market Size Forecast
10.2 Global Parkinson's Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson's Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Parkinson's Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinson's Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson's Disease Therapeutics by Type (2025-2030)
11.1.2 Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson's Disease Therapeutics by Type (2025-2030)
11.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Parkinson's Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinson's Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson's Disease Therapeutics Segment by Type
1.2.2 Parkinson's Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson's Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinson's Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson's Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson's Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson's Disease Therapeutics Price by Type (2019-2024)
7 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson's Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 PARKINSON'S DISEASE THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.2 Global Parkinson's Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Parkinson's Disease Therapeutics Basic Information
9.1.2 Merck Parkinson's Disease Therapeutics Product Overview
9.1.3 Merck Parkinson's Disease Therapeutics Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Parkinson's Disease Therapeutics SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Akorn
9.2.1 Akorn Parkinson's Disease Therapeutics Basic Information
9.2.2 Akorn Parkinson's Disease Therapeutics Product Overview
9.2.3 Akorn Parkinson's Disease Therapeutics Product Market Performance
9.2.4 Akorn Business Overview
9.2.5 Akorn Parkinson's Disease Therapeutics SWOT Analysis
9.2.6 Akorn Recent Developments
9.3 GSK
9.3.1 GSK Parkinson's Disease Therapeutics Basic Information
9.3.2 GSK Parkinson's Disease Therapeutics Product Overview
9.3.3 GSK Parkinson's Disease Therapeutics Product Market Performance
9.3.4 GSK Parkinson's Disease Therapeutics SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Novartis
9.4.1 Novartis Parkinson's Disease Therapeutics Basic Information
9.4.2 Novartis Parkinson's Disease Therapeutics Product Overview
9.4.3 Novartis Parkinson's Disease Therapeutics Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
9.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
9.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Recent Developments
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
9.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
9.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Market Performance
9.6.4 Teva Pharmaceutical Business Overview
9.6.5 Teva Pharmaceutical Recent Developments
9.7 Abbvie
9.7.1 Abbvie Parkinson's Disease Therapeutics Basic Information
9.7.2 Abbvie Parkinson's Disease Therapeutics Product Overview
9.7.3 Abbvie Parkinson's Disease Therapeutics Product Market Performance
9.7.4 Abbvie Business Overview
9.7.5 Abbvie Recent Developments
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
9.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
9.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Market Performance
9.8.4 Kyowa Hakko Kirin Pharma Business Overview
9.8.5 Kyowa Hakko Kirin Pharma Recent Developments
9.9 Astellas Pharma
9.9.1 Astellas Pharma Parkinson's Disease Therapeutics Basic Information
9.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Overview
9.9.3 Astellas Pharma Parkinson's Disease Therapeutics Product Market Performance
9.9.4 Astellas Pharma Business Overview
9.9.5 Astellas Pharma Recent Developments
9.10 Roche
9.10.1 Roche Parkinson's Disease Therapeutics Basic Information
9.10.2 Roche Parkinson's Disease Therapeutics Product Overview
9.10.3 Roche Parkinson's Disease Therapeutics Product Market Performance
9.10.4 Roche Business Overview
9.10.5 Roche Recent Developments
9.11 H.Lundbeck
9.11.1 H.Lundbeck Parkinson's Disease Therapeutics Basic Information
9.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Overview
9.11.3 H.Lundbeck Parkinson's Disease Therapeutics Product Market Performance
9.11.4 H.Lundbeck Business Overview
9.11.5 H.Lundbeck Recent Developments
9.12 Bausch Health
9.12.1 Bausch Health Parkinson's Disease Therapeutics Basic Information
9.12.2 Bausch Health Parkinson's Disease Therapeutics Product Overview
9.12.3 Bausch Health Parkinson's Disease Therapeutics Product Market Performance
9.12.4 Bausch Health Business Overview
9.12.5 Bausch Health Recent Developments
9.13 Apokyn
9.13.1 Apokyn Parkinson's Disease Therapeutics Basic Information
9.13.2 Apokyn Parkinson's Disease Therapeutics Product Overview
9.13.3 Apokyn Parkinson's Disease Therapeutics Product Market Performance
9.13.4 Apokyn Business Overview
9.13.5 Apokyn Recent Developments
9.14 Orion
9.14.1 Orion Parkinson's Disease Therapeutics Basic Information
9.14.2 Orion Parkinson's Disease Therapeutics Product Overview
9.14.3 Orion Parkinson's Disease Therapeutics Product Market Performance
9.14.4 Orion Business Overview
9.14.5 Orion Recent Developments
9.15 Stada Arzneimittel
9.15.1 Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
9.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
9.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
9.15.4 Stada Arzneimittel Business Overview
9.15.5 Stada Arzneimittel Recent Developments
9.16 US WorldMeds
9.16.1 US WorldMeds Parkinson's Disease Therapeutics Basic Information
9.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Overview
9.16.3 US WorldMeds Parkinson's Disease Therapeutics Product Market Performance
9.16.4 US WorldMeds Business Overview
9.16.5 US WorldMeds Recent Developments
9.17 Desitin Arzneimittel
9.17.1 Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
9.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
9.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
9.17.4 Desitin Arzneimittel Business Overview
9.17.5 Desitin Arzneimittel Recent Developments
9.18 Endo Pharmaceuticals
9.18.1 Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
9.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
9.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Market Performance
9.18.4 Endo Pharmaceuticals Business Overview
9.18.5 Endo Pharmaceuticals Recent Developments
10 PARKINSON'S DISEASE THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Parkinson's Disease Therapeutics Market Size Forecast
10.2 Global Parkinson's Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson's Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Parkinson's Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinson's Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson's Disease Therapeutics by Type (2025-2030)
11.1.2 Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson's Disease Therapeutics by Type (2025-2030)
11.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Parkinson's Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson's Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson's Disease Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Parkinson's Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson's Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson's Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson's Disease Therapeutics Product Type
Table 13. Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson's Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease Therapeutics Market Challenges
Table 22. Global Parkinson's Disease Therapeutics Sales by Type (K Units)
Table 23. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson's Disease Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson's Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson's Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson's Disease Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Parkinson's Disease Therapeutics Sales (K Units) by Application
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application
Table 31. Global Parkinson's Disease Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson's Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson's Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Merck Parkinson's Disease Therapeutics Basic Information
Table 44. Merck Parkinson's Disease Therapeutics Product Overview
Table 45. Merck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Parkinson's Disease Therapeutics SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Akorn Parkinson's Disease Therapeutics Basic Information
Table 50. Akorn Parkinson's Disease Therapeutics Product Overview
Table 51. Akorn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Akorn Business Overview
Table 53. Akorn Parkinson's Disease Therapeutics SWOT Analysis
Table 54. Akorn Recent Developments
Table 55. GSK Parkinson's Disease Therapeutics Basic Information
Table 56. GSK Parkinson's Disease Therapeutics Product Overview
Table 57. GSK Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GSK Parkinson's Disease Therapeutics SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Novartis Parkinson's Disease Therapeutics Basic Information
Table 62. Novartis Parkinson's Disease Therapeutics Product Overview
Table 63. Novartis Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novartis Business Overview
Table 65. Novartis Recent Developments
Table 66. Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
Table 67. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
Table 68. Boehringer Ingelheim Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Recent Developments
Table 71. Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
Table 72. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
Table 73. Teva Pharmaceutical Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Teva Pharmaceutical Business Overview
Table 75. Teva Pharmaceutical Recent Developments
Table 76. Abbvie Parkinson's Disease Therapeutics Basic Information
Table 77. Abbvie Parkinson's Disease Therapeutics Product Overview
Table 78. Abbvie Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Abbvie Business Overview
Table 80. Abbvie Recent Developments
Table 81. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
Table 82. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
Table 83. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Kyowa Hakko Kirin Pharma Business Overview
Table 85. Kyowa Hakko Kirin Pharma Recent Developments
Table 86. Astellas Pharma Parkinson's Disease Therapeutics Basic Information
Table 87. Astellas Pharma Parkinson's Disease Therapeutics Product Overview
Table 88. Astellas Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Astellas Pharma Business Overview
Table 90. Astellas Pharma Recent Developments
Table 91. Roche Parkinson's Disease Therapeutics Basic Information
Table 92. Roche Parkinson's Disease Therapeutics Product Overview
Table 93. Roche Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Roche Business Overview
Table 95. Roche Recent Developments
Table 96. H.Lundbeck Parkinson's Disease Therapeutics Basic Information
Table 97. H.Lundbeck Parkinson's Disease Therapeutics Product Overview
Table 98. H.Lundbeck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. H.Lundbeck Business Overview
Table 100. H.Lundbeck Recent Developments
Table 101. Bausch Health Parkinson's Disease Therapeutics Basic Information
Table 102. Bausch Health Parkinson's Disease Therapeutics Product Overview
Table 103. Bausch Health Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Bausch Health Business Overview
Table 105. Bausch Health Recent Developments
Table 106. Apokyn Parkinson's Disease Therapeutics Basic Information
Table 107. Apokyn Parkinson's Disease Therapeutics Product Overview
Table 108. Apokyn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Apokyn Business Overview
Table 110. Apokyn Recent Developments
Table 111. Orion Parkinson's Disease Therapeutics Basic Information
Table 112. Orion Parkinson's Disease Therapeutics Product Overview
Table 113. Orion Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Orion Business Overview
Table 115. Orion Recent Developments
Table 116. Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
Table 117. Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 118. Stada Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Stada Arzneimittel Business Overview
Table 120. Stada Arzneimittel Recent Developments
Table 121. US WorldMeds Parkinson's Disease Therapeutics Basic Information
Table 122. US WorldMeds Parkinson's Disease Therapeutics Product Overview
Table 123. US WorldMeds Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. US WorldMeds Business Overview
Table 125. US WorldMeds Recent Developments
Table 126. Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
Table 127. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 128. Desitin Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Desitin Arzneimittel Business Overview
Table 130. Desitin Arzneimittel Recent Developments
Table 131. Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
Table 132. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
Table 133. Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Endo Pharmaceuticals Business Overview
Table 135. Endo Pharmaceuticals Recent Developments
Table 136. Global Parkinson's Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Parkinson's Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Parkinson's Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Parkinson's Disease Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Parkinson's Disease Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Parkinson's Disease Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Parkinson's Disease Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinson's Disease Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Parkinson's Disease Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Parkinson's Disease Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinson's Disease Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2022)
Table 10. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinson's Disease Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Parkinson's Disease Therapeutics Product Type
Table 13. Global Parkinson's Disease Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinson's Disease Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease Therapeutics Market Challenges
Table 22. Global Parkinson's Disease Therapeutics Sales by Type (K Units)
Table 23. Global Parkinson's Disease Therapeutics Market Size by Type (M USD)
Table 24. Global Parkinson's Disease Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Parkinson's Disease Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinson's Disease Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Parkinson's Disease Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Parkinson's Disease Therapeutics Sales (K Units) by Application
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application
Table 31. Global Parkinson's Disease Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Parkinson's Disease Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinson's Disease Therapeutics Market Share by Application (2019-2024)
Table 35. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Parkinson's Disease Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Parkinson's Disease Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Merck Parkinson's Disease Therapeutics Basic Information
Table 44. Merck Parkinson's Disease Therapeutics Product Overview
Table 45. Merck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Parkinson's Disease Therapeutics SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Akorn Parkinson's Disease Therapeutics Basic Information
Table 50. Akorn Parkinson's Disease Therapeutics Product Overview
Table 51. Akorn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Akorn Business Overview
Table 53. Akorn Parkinson's Disease Therapeutics SWOT Analysis
Table 54. Akorn Recent Developments
Table 55. GSK Parkinson's Disease Therapeutics Basic Information
Table 56. GSK Parkinson's Disease Therapeutics Product Overview
Table 57. GSK Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GSK Parkinson's Disease Therapeutics SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. Novartis Parkinson's Disease Therapeutics Basic Information
Table 62. Novartis Parkinson's Disease Therapeutics Product Overview
Table 63. Novartis Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novartis Business Overview
Table 65. Novartis Recent Developments
Table 66. Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
Table 67. Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
Table 68. Boehringer Ingelheim Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Recent Developments
Table 71. Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
Table 72. Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
Table 73. Teva Pharmaceutical Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Teva Pharmaceutical Business Overview
Table 75. Teva Pharmaceutical Recent Developments
Table 76. Abbvie Parkinson's Disease Therapeutics Basic Information
Table 77. Abbvie Parkinson's Disease Therapeutics Product Overview
Table 78. Abbvie Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Abbvie Business Overview
Table 80. Abbvie Recent Developments
Table 81. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
Table 82. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
Table 83. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Kyowa Hakko Kirin Pharma Business Overview
Table 85. Kyowa Hakko Kirin Pharma Recent Developments
Table 86. Astellas Pharma Parkinson's Disease Therapeutics Basic Information
Table 87. Astellas Pharma Parkinson's Disease Therapeutics Product Overview
Table 88. Astellas Pharma Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Astellas Pharma Business Overview
Table 90. Astellas Pharma Recent Developments
Table 91. Roche Parkinson's Disease Therapeutics Basic Information
Table 92. Roche Parkinson's Disease Therapeutics Product Overview
Table 93. Roche Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Roche Business Overview
Table 95. Roche Recent Developments
Table 96. H.Lundbeck Parkinson's Disease Therapeutics Basic Information
Table 97. H.Lundbeck Parkinson's Disease Therapeutics Product Overview
Table 98. H.Lundbeck Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. H.Lundbeck Business Overview
Table 100. H.Lundbeck Recent Developments
Table 101. Bausch Health Parkinson's Disease Therapeutics Basic Information
Table 102. Bausch Health Parkinson's Disease Therapeutics Product Overview
Table 103. Bausch Health Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Bausch Health Business Overview
Table 105. Bausch Health Recent Developments
Table 106. Apokyn Parkinson's Disease Therapeutics Basic Information
Table 107. Apokyn Parkinson's Disease Therapeutics Product Overview
Table 108. Apokyn Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Apokyn Business Overview
Table 110. Apokyn Recent Developments
Table 111. Orion Parkinson's Disease Therapeutics Basic Information
Table 112. Orion Parkinson's Disease Therapeutics Product Overview
Table 113. Orion Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Orion Business Overview
Table 115. Orion Recent Developments
Table 116. Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
Table 117. Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 118. Stada Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Stada Arzneimittel Business Overview
Table 120. Stada Arzneimittel Recent Developments
Table 121. US WorldMeds Parkinson's Disease Therapeutics Basic Information
Table 122. US WorldMeds Parkinson's Disease Therapeutics Product Overview
Table 123. US WorldMeds Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. US WorldMeds Business Overview
Table 125. US WorldMeds Recent Developments
Table 126. Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
Table 127. Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
Table 128. Desitin Arzneimittel Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Desitin Arzneimittel Business Overview
Table 130. Desitin Arzneimittel Recent Developments
Table 131. Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
Table 132. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
Table 133. Endo Pharmaceuticals Parkinson's Disease Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Endo Pharmaceuticals Business Overview
Table 135. Endo Pharmaceuticals Recent Developments
Table 136. Global Parkinson's Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Parkinson's Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Parkinson's Disease Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Parkinson's Disease Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Parkinson's Disease Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Parkinson's Disease Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Parkinson's Disease Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Parkinson's Disease Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Parkinson's Disease Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinson's Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Parkinson's Disease Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Parkinson's Disease Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson's Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson's Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson's Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson's Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson's Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson's Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson's Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson's Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson's Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Parkinson's Disease Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson's Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Parkinson's Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Parkinson's Disease Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Parkinson's Disease Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinson's Disease Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinson's Disease Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Parkinson's Disease Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Parkinson's Disease Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Parkinson's Disease Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease Therapeutics Market Size by Country (M USD)
Figure 11. Parkinson's Disease Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Parkinson's Disease Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinson's Disease Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Type
Figure 18. Sales Market Share of Parkinson's Disease Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Parkinson's Disease Therapeutics by Type in 2023
Figure 20. Market Size Share of Parkinson's Disease Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinson's Disease Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinson's Disease Therapeutics Market Share by Application
Figure 24. Global Parkinson's Disease Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinson's Disease Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Parkinson's Disease Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Parkinson's Disease Therapeutics Market Share by Application in 2023
Figure 28. Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinson's Disease Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Parkinson's Disease Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinson's Disease Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Parkinson's Disease Therapeutics Sales Market Share by Region in 2023
Figure 44. China Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Parkinson's Disease Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Parkinson's Disease Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Parkinson's Disease Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Parkinson's Disease Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Parkinson's Disease Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Parkinson's Disease Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinson's Disease Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinson's Disease Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2025-2030)
